Tools within the WeightWatchers GLP-1 Success program, such as meal planning and habit tracking, help connect your medication use with everyday routines
They work by slowing down how quickly food leaves your stomach, which helps you feel satisfied longer, and by signaling to your brain that you're full, reducing hunger and food cravings
This study aims to explore this gap by utilizing data from the large community-based database, TriNetX, to investigate the association between GLP-1 RA use and the risk of psychiatric diseases, including major depression, anxiety and suicidal behaviour in patients with obesity
The European Medicines Agency (EMA) recently launched an investigation into Novo Nordisk's GLP-1 treatments, including Saxenda (ingredient: liraglutide), Ozempic (ingredient: semaglutide), and Wegovy (ingredient: semaglutide), after the Icelandic Medicines Agency reported two adverse events of suicidal or self-harming behavior in patients taking Saxenda and Ozempic
What it is Retatrutide (5mg) is supplied as a lyophilized reference compound for investigators in glp-1 / glp-3 receptor agonists research
In a RCT by Lin et al
/assets/images/provider/photos/2736093.png)
